← Back to Intel
Insider ActivityMLYS
Congleton Jon, Chief Executive Officer, Director at Mineralys Therapeutics, Inc., sold $422K of MLYS
Updated Jun 20, 2026
Congleton Jon
Chief Executive Officer, Director
Mineralys Therapeutics, Inc. ·
$MLYS
Transaction Details
| Insider | Congleton Jon |
|---|---|
| Title | Chief Executive Officer, Director |
| Company | Mineralys Therapeutics, Inc. |
| Ticker | MLYS |
| Transaction Type | Sale |
| Transaction Date | 2026-04-13 |
| Shares Traded | 15,730 |
| Price Per Share | $26.8264 |
| Total Value | $422K |
| Filed Date | 2026-04-15 |
| Accession Number | 0001933414-26-000075 |
Ownership Context
| Shares Owned After Transaction | 689,321 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001933414-26-000075
Other Insider Trades — MLYS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Rodman David Malcom | Chief Medical Officer | traded | $6K | 2026-06-17 |
| Rodman David Malcom | Chief Medical Officer | sold | $115K | 2026-06-17 |
| Karydas Daphne | Director | sold | $75K | 2026-06-17 |
| Karydas Daphne | Director | traded | $36K | 2026-06-17 |
| Rodman David Malcom | Chief Medical Officer | traded | $59K | 2026-06-17 |
| Rodman David Malcom | Chief Medical Officer | traded | $36K | 2026-06-15 |
| Rodman David Malcom | Chief Medical Officer | sold | $235K | 2026-06-15 |
| Rodman David Malcom | Chief Medical Officer | traded | $7K | 2026-06-12 |
| Rodman David Malcom | Chief Medical Officer | sold | $152K | 2026-06-12 |
| Rodman David Malcom | Chief Medical Officer | sold | $54K | 2026-06-10 |
Other Trades by Congleton Jon
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| AVLN | Avalyn Pharma Inc. | traded | — | 2026-04-29 |
| MLYS | Mineralys Therapeutics, Inc. | sold | $494K | 2026-03-31 |
| MLYS | Mineralys Therapeutics, Inc. | sold | $1.5M | 2026-03-31 |
| MLYS | Mineralys Therapeutics, Inc. | sold | $12K | 2026-03-31 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →
Track MLYS insider activity in real time on The Wire →
Get alerts when Congleton Jon files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 20, 2026 at 07:21 UTC